Brief: Nanjing Leads Biolabs Posts HY Loss Attributable RMB221.9 Million
31/08/2026 11:22
BRIEF-Nanjing Leads Biolabs Posts HY Loss Attributable RMB221.9 Million Aug 31 (Reuters) - Nanjing Leads Biolabs Co Ltd 9887.HK:
HY LOSS ATTRIBUTABLE RMB221.9 MILLION
HY REVENUE RMB36 MILLION
BOARD DID NOT RECOMMEND AN INTERIM DIVIDEND
Further company coverage: 9887.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanjing Leads Biolabs
See all newsBrief: Nanjing Leads Biolabs Says FDA Grants Fast Track Designation To LBL-024
Brief: Nanjing Leads Biolabs Posts HY Loss Attributable RMB221.9 Million
Nanjing Leads rises on clinical study progress on cancer treatment drug
Nanjing Leads Biolabs jumps on progress of tumor antibody treatment
Nanjing Leads Biolabs rises on NMPA's IND approval for colorectal cancer